Compare VISTA PHARMA with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VISTA PHARMA vs ADVANCED ENZYME TECHNOLOGIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VISTA PHARMA ADVANCED ENZYME TECHNOLOGIES VISTA PHARMA/
ADVANCED ENZYME TECHNOLOGIES
 
P/E (TTM) x -11.6 24.7 - View Chart
P/BV x 1.1 3.8 29.0% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 VISTA PHARMA   ADVANCED ENZYME TECHNOLOGIES
EQUITY SHARE DATA
    VISTA PHARMA
Mar-21
ADVANCED ENZYME TECHNOLOGIES
Mar-21
VISTA PHARMA/
ADVANCED ENZYME TECHNOLOGIES
5-Yr Chart
Click to enlarge
High Rs16417 3.9%   
Low Rs5129 3.7%   
Sales per share (Unadj.) Rs0.344.9 0.8%  
Earnings per share (Unadj.) Rs-0.513.6 -3.8%  
Cash flow per share (Unadj.) Rs-0.316.1 -2.0%  
Dividends per share (Unadj.) Rs00.60 0.0%  
Avg Dividend yield %00.2 0.0%  
Book value per share (Unadj.) Rs8.986.6 10.3%  
Shares outstanding (eoy) m36.79111.73 32.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x30.36.1 499.4%   
Avg P/E ratio x-20.420.1 -101.3%  
P/CF ratio (eoy) x-33.217.0 -195.9%  
Price / Book Value ratio x1.23.1 37.1%  
Dividend payout %04.4 0.0%   
Avg Mkt Cap Rs m38430,491 1.3%   
No. of employees `000NANA-   
Total wages/salary Rs m12871 1.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m135,018 0.3%  
Other income Rs m388 3.6%   
Total revenues Rs m165,107 0.3%   
Gross profit Rs m-172,325 -0.7%  
Depreciation Rs m7284 2.6%   
Interest Rs m1526 60.6%   
Profit before tax Rs m-372,104 -1.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-18589 -3.1%   
Profit after tax Rs m-191,515 -1.2%  
Gross profit margin %-136.646.3 -294.9%  
Effective tax rate %48.928.0 174.6%   
Net profit margin %-148.930.2 -493.4%  
BALANCE SHEET DATA
Current assets Rs m1525,161 3.0%   
Current liabilities Rs m92676 13.7%   
Net working cap to sales %473.289.4 529.5%  
Current ratio x1.67.6 21.6%  
Inventory Days Days2,409102 2,367.9%  
Debtors Days Days6,25463 9,966.7%  
Net fixed assets Rs m3746,297 5.9%   
Share capital Rs m74223 32.9%   
"Free" reserves Rs m2559,457 2.7%   
Net worth Rs m3289,680 3.4%   
Long term debt Rs m8799 88.1%   
Total assets Rs m52611,458 4.6%  
Interest coverage x-1.483.3 -1.7%   
Debt to equity ratio x0.30 2,595.6%  
Sales to assets ratio x00.4 5.5%   
Return on assets %-0.613.4 -4.8%  
Return on equity %-5.715.6 -36.7%  
Return on capital %-5.121.8 -23.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m10-   
Fx outflow Rs m00-   
Net fx Rs m10-   
CASH FLOW
From Operations Rs m-671,629 -4.1%  
From Investments Rs m-3-260 1.1%  
From Financial Activity Rs m70-263 -26.5%  
Net Cashflow Rs m-11,093 -0.1%  

Share Holding

Indian Promoters % 2.0 11.9 17.2%  
Foreign collaborators % 34.9 40.7 85.8%  
Indian inst/Mut Fund % 0.2 24.9 0.6%  
FIIs % 0.1 16.3 0.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 63.1 47.5 132.9%  
Shareholders   13,004 87,112 14.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VISTA PHARMA With:   GLENMARK PHARMA  HEMO ORGANIC  AMRUTANJAN HEALTHCARE  JUBILANT PHARMOVA   DISHMAN PHARMA  



Today's Market

SGX Nifty Up 51 Points, India's Fiscal Deficit, Anand Rathi Wealth IPO, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a negative note yesterday. Benchmark indices edged lower as global cues turned bearish after US pharma.

Related Views on News

ADVANCED ENZYME TECHNOLOGIES 2020-21 Annual Report Analysis (Annual Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

Here's an analysis of the annual report of ADVANCED ENZYME TECHNOLOGIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of ADVANCED ENZYME TECHNOLOGIES. Also includes updates on the valuation of ADVANCED ENZYME TECHNOLOGIES.

ADVANCED ENZYME TECHNOLOGIES Announces Quarterly Results (1QFY22); Net Profit Up 14.5% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, ADVANCED ENZYME TECHNOLOGIES has posted a net profit of Rs 399 m (up 14.5% YoY). Sales on the other hand came in at Rs 1 bn (up 24.0% YoY). Read on for a complete analysis of ADVANCED ENZYME TECHNOLOGIES's quarterly results.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

How to Find Your Next 10-Bagger in this Market(Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

VISTA PHARMA SHARE PRICE


Nov 30, 2021 (Close)

TRACK VISTA PHARMA

  • Track your investment in VISTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

VISTA PHARMA - ALKEM LABORATORIES COMPARISON

COMPARE VISTA PHARMA WITH

MARKET STATS